Since this medicine is usually administered in the clinical/hospital setting, the likelihood of a missed dose is very low. However, since this medicine is usually given in multiple cycles, if you miss a scheduled dose of this medicine, call your doctor immediately for further instructions.
Since this medicine is usually administered in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Griseofulvin (moderate)
Indapamide (moderate)
Tizanidine (severe)
Methotrexate (moderate)
Norfloxacin (moderate)
Prochlorperazine (moderate)
This medicine is used with light therapy for the treatment of vitiligo, a skin condition characterized by loss of skin color in patches. It stimulates melanocytes (melanin forming skin cells) to move up the hair follicle and to repopulate the epidermis.
This medicine is used in combination with UVA light therapy for the treatment of psoriasis, a skin disease characterized by excessive scaling, dryness, rashes, and itching of the skin.
Redness of the skin
Itching
Nausea
Trouble sleeping (rare)
Darkening of skin
Low blood pressure
Blistering and peeling of skin
Swelling in the arms or legs (rare)
This medicine is not recommended for use in patients with a known allergy to AMMOIDIN 10mg Tablet 30s , any psoralen compounds, or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients suffering from aphakia (a condition of absence or not having eye lens) due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with a history of melanoma due to the increased risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with invasive squamous cell carcinomas due to the increased risk of worsening of the patient's condition.